Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.
The report details the trend, potential and market size of Pegvisomant Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pegvisomant Drugsmarket, defines the market attractiveness level of Pegvisomant Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pegvisomant Drugs industry, describes the types of Pegvisomant Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pegvisomant Drugs market and the development prospects and opportunities of Pegvisomant Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pegvisomant Drugs market in Chapter 13.
By Player:
Pfizer
By Type:
Prefilled
Non-prefilled
By End-User:
Hospital
Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pegvisomant Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pegvisomant Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pegvisomant Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pegvisomant Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pegvisomant Drugs Market Analysis and Outlook to 2022
-
7.1 Global Pegvisomant Drugs Consumption (2017-2022)
-
7.2 United States Pegvisomant Drugs Consumption (2017-2022)
-
7.3 Europe Pegvisomant Drugs Consumption (2017-2022)
-
7.4 China Pegvisomant Drugs Consumption (2017-2022)
-
7.5 Japan Pegvisomant Drugs Consumption (2017-2022)
-
7.6 India Pegvisomant Drugs Consumption (2017-2022)
-
7.7 South Korea Pegvisomant Drugs Consumption (2017-2022)
8 Region and Country-wise Pegvisomant Drugs Market Analysis and Outlook to 2028
-
8.1 Global Pegvisomant Drugs Consumption Forecast (2022-2028)
-
8.2 United States Pegvisomant Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Pegvisomant Drugs Consumption Forecast (2022-2028)
-
8.4 China Pegvisomant Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Pegvisomant Drugs Consumption Forecast (2022-2028)
-
8.6 India Pegvisomant Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Pegvisomant Drugs Consumption Forecast (2022-2028)
9 Global Pegvisomant Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Pegvisomant Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prefilled Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-prefilled Consumption and Growth Rate (2017-2022)
-
9.2 Global Pegvisomant Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Pegvisomant Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Pegvisomant Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prefilled Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-prefilled Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pegvisomant Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Pegvisomant Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pegvisomant Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pegvisomant Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pegvisomant Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pegvisomant Drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Pegvisomant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Pegvisomant Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pegvisomant Drugs
-
Figure Pegvisomant Drugs Picture
-
Table Global Pegvisomant Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pegvisomant Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pegvisomant Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pegvisomant Drugs Consumption by Country (2017-2022)
-
Figure United States Pegvisomant Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Pegvisomant Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Pegvisomant Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Pegvisomant Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Pegvisomant Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pegvisomant Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pegvisomant Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Pegvisomant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pegvisomant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pegvisomant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pegvisomant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pegvisomant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pegvisomant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prefilled Consumption and Growth Rate (2017-2022)
-
Figure Global Non-prefilled Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Prefilled Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-prefilled Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pegvisomant Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pegvisomant Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pegvisomant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pegvisomant Drugs Product and Service
-
